These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16773207)

  • 1. A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent.
    Kim HL; Yeo EJ; Chun YS; Park JW
    Int J Oncol; 2006 Jul; 29(1):255-60. PubMed ID: 16773207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
    Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
    Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading.
    Shin DH; Kim JH; Jung YJ; Kim KE; Jeong JM; Chun YS; Park JW
    Cancer Lett; 2007 Sep; 255(1):107-16. PubMed ID: 17502124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
    Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
    Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
    Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
    Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of YC-1 targeting hypoxia-inducible factor 1 alpha in oesophageal squamous carcinoma cell line Eca109 cells.
    Feng Y; Zhu H; Ling T; Hao B; Zhang G; Shi R
    Cell Biol Int; 2011 May; 35(5):491-7. PubMed ID: 20977428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
    Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of YC-1 on induction of VEGF and GPI genes in hypoxic human pancreatic cancer cells].
    Du J; Zhao Q; Gu H; Teng XL; Qin H; Liu NZ
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):486-9. PubMed ID: 17147109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
    Creighton-Gutteridge M; Cardellina JH; Stephen AG; Rapisarda A; Uranchimeg B; Hite K; Denny WA; Shoemaker RH; Melillo G
    Clin Cancer Res; 2007 Feb; 13(3):1010-8. PubMed ID: 17289897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha.
    Lim JH; Park JW; Kim MS; Park SK; Johnson RS; Chun YS
    Mol Pharmacol; 2006 Dec; 70(6):1856-65. PubMed ID: 16940187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
    Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
    Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression.
    Yeh WL; Lu DY; Lin CJ; Liou HC; Fu WM
    Mol Pharmacol; 2007 Aug; 72(2):440-9. PubMed ID: 17513385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UVC inhibits HIF-1alpha protein translation by a DNA damage- and topoisomerase I-independent pathway.
    Rapisarda A; Melillo G
    Oncogene; 2007 Oct; 26(48):6875-84. PubMed ID: 17496931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2).
    Lau CK; Yang ZF; Lam CT; Tam KH; Poon RT; Fan ST
    Biochem Biophys Res Commun; 2006 Oct; 348(4):1443-8. PubMed ID: 16919599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-glucosamine down-regulates HIF-1alpha through inhibition of protein translation in DU145 prostate cancer cells.
    Park JY; Park JW; Suh SI; Baek WK
    Biochem Biophys Res Commun; 2009 Apr; 382(1):96-101. PubMed ID: 19254699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1alpha.
    Peng ZG; Zhou MY; Huang Y; Qiu JH; Wang LS; Liao SH; Dong S; Chen GQ
    Oncogene; 2008 Jan; 27(6):839-47. PubMed ID: 17684492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway.
    Won MS; Im N; Park S; Boovanahalli SK; Jin Y; Jin X; Chung KS; Kang M; Lee K; Park SK; Kim HM; Kwon BM; Lee JJ; Lee K
    Biochem Biophys Res Commun; 2009 Jul; 385(1):16-21. PubMed ID: 19433063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha.
    Kim HJ; Chung H; Yoo YG; Kim H; Lee JY; Lee MO; Kong G
    Mol Cancer Res; 2007 Apr; 5(4):321-9. PubMed ID: 17426247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating transcription factor 2 increases transactivation and protein stability of hypoxia-inducible factor 1alpha in hepatocytes.
    Choi JH; Cho HK; Choi YH; Cheong J
    Biochem J; 2009 Nov; 424(2):285-96. PubMed ID: 19712049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
    Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
    Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.